Recombinant Putative S-adenosyl-L-methionine-dependent methyltransferase MAP_0882c (MAP_0882c) is an enzyme that catalyzes the transfer of a methyl group from S-adenosyl-L-methionine (SAM) to a specific substrate. Methyltransferases are a large family of enzymes that play a role in many biological processes, including DNA methylation, protein methylation, and the biosynthesis of various metabolites . SAM-dependent methyltransferases utilize SAM as a cofactor .
Methylation Activity: MAP_0882c is predicted to be involved in methylation reactions. Methylation can alter the activity of proteins or DNA .
Substrate Specificity: Identifying the natural substrate of MAP_0882c is crucial for understanding its biological role. This can be achieved through biochemical assays and structural studies.
Enzyme kinetics: The catalytic efficiency of MAP_0882c can be determined by measuring the rate of methylation with respect to different substrate concentrations.
Based on sequence homology and functional studies, MAP_0882c may be involved in:
Metabolic Pathways: Participating in the biosynthesis or modification of specific metabolites.
Regulation: Modulating the activity of other proteins through methylation.
Stress Response: Altering protein function in response to environmental changes.
Relevant experimental techniques for studying MAP_0882c include:
Recombinant Expression and Purification: Expressing the MAP_0882c gene in a suitable host organism (e.g., E. coli) and purifying the recombinant protein for in vitro studies.
Crystallography: Determining the three-dimensional structure of MAP_0882c by X-ray crystallography to understand its active site and substrate-binding mechanism .
Site-Directed Mutagenesis: Mutating specific amino acid residues in MAP_0882c to assess their roles in catalysis and substrate binding.
Mass Spectrometry: Identifying the methylated products of MAP_0882c using mass spectrometry.
KEGG: mpa:MAP_0882c
STRING: 262316.MAP0882c
MAP_0882c is a gene that encodes a putative S-adenosyl-L-methionine-dependent methyltransferase identified in Mycobacterium paratuberculosis, the causative agent of Johne's disease in cattle and other ruminants. This protein belongs to a class of enzymes that utilize S-adenosyl-L-methionine (SAM) as a methyl donor to catalyze methylation reactions. According to database records, MAP_0882c is classified under "Putative S-adenosyl-L-methionine-dependent methyltransferase MAP_0882c" in protein databases, indicating its predicted function has been assigned based on sequence homology rather than direct experimental validation .
S-adenosyl-L-methionine (SAM)-dependent methyltransferases share common structural elements despite diverse substrate specificities. These enzymes typically contain:
A characteristic Rossmann-like fold for SAM binding
Several conserved sequence motifs including:
Functionally, these enzymes catalyze the transfer of a methyl group from SAM to various substrates including DNA, RNA, proteins, and small molecules. This methylation can alter molecular interactions, gene expression, protein function, or metabolite activity depending on the specific substrate. The reaction produces S-adenosyl-homocysteine (SAH) as a byproduct, which typically acts as a product inhibitor of these enzymes .
While the search results don't provide specific conservation data for MAP_0882c across mycobacterial species, we can infer several points from the available information:
MAP_0882c appears to be one of several putative methyltransferases in Mycobacterium paratuberculosis, as indicated by the existence of other related genes (MAP_0663, MAP_2076c, MAP_3385, MAP_3563, MAP_3881, MAP_4079, and MAP_4190c) .
S-adenosyl-L-methionine-dependent methyltransferases are widely distributed across bacteria, including mycobacteria, suggesting conservation of this enzyme class if not the specific protein.
To determine conservation of MAP_0882c specifically, researchers should:
Perform BLAST searches against mycobacterial genomes
Create multiple sequence alignments of putative homologs
Construct phylogenetic trees to visualize evolutionary relationships
Analyze genomic context to identify synteny (conservation of gene neighborhoods)
A comprehensive conservation analysis would provide insights into the evolutionary importance of this enzyme and help predict its functional significance in mycobacterial physiology or pathogenesis.
Expression and purification of recombinant MAP_0882c can be achieved using the following methodological approach:
Cloning strategy:
Amplify the MAP_0882c gene from Mycobacterium paratuberculosis genomic DNA using PCR with primers containing appropriate restriction sites
Clone the gene into an expression vector with an N- or C-terminal affinity tag (His, GST, etc.)
Verify the construct by sequencing to ensure no mutations were introduced
Expression systems:
According to product information, MAP_0882c has been successfully expressed in multiple systems:
Purification protocol:
Culture cells under optimized conditions (temperature, induction time, inducer concentration)
Harvest cells by centrifugation and lyse using sonication, French press, or detergents
Clarify lysate by centrifugation (20,000 × g, 30 min, 4°C)
Perform affinity chromatography:
For His-tagged protein: Ni-NTA or TALON resin
For GST-tagged protein: Glutathione Sepharose
Elute with appropriate buffer (imidazole for His-tag, reduced glutathione for GST-tag)
Further purify using size exclusion chromatography to remove aggregates and contaminants
Verify purity by SDS-PAGE and identity by western blotting or mass spectrometry
Quality control:
Verify protein folding using circular dichroism or fluorescence spectroscopy
Determine oligomeric state using analytical size exclusion chromatography
Assess enzymatic activity using appropriate methyltransferase assays
Evaluate protein stability by thermal shift assay
This approach is similar to methods used for other methyltransferases, such as the METTL21A methyltransferase described in the literature .
Several complementary approaches can be employed to assay the methyltransferase activity of MAP_0882c:
Radiometric assays:
Incubate purified MAP_0882c with [³H] or [¹⁴C]-labeled SAM and potential substrates
Separate reaction products by:
TCA precipitation for protein substrates
Filter binding for nucleic acid substrates
HPLC for small molecule substrates
Quantify incorporated radioactivity by scintillation counting
Advantages: high sensitivity, direct measurement of methyl transfer
Limitations: requires radioisotope handling, disposal concerns
Mass spectrometry-based assays:
Incubate enzyme with SAM and substrate under optimized conditions
Digest protein substrates with proteases for peptide-level analysis
Analyze by LC-MS/MS to identify:
Mass shifts of +14 Da indicating methylation
Location of methylation sites
Degree of methylation (mono-, di-, or tri-methylation)
Advantages: site-specific identification, quantitative analysis possible
Limitations: requires specialized equipment and expertise
Coupled enzymatic assays:
Link SAH production to a secondary reaction that produces a detectable signal
For example, the SAH generated can be converted to homocysteine by SAH nucleosidase, then to hydrogen sulfide by cystathionine β-lyase, which can react with a colorimetric reagent
Advantages: continuous monitoring, adaptable to high-throughput screening
Limitations: potential interference from coupling enzymes or compounds
Antibody-based detection:
Use antibodies specific to methylated residues (e.g., anti-methyl-lysine, anti-methyl-arginine)
Detect methylated products by western blot, ELISA, or immunofluorescence
Advantages: can be used for in vitro and cellular samples
Limitations: dependent on antibody specificity, may not detect all methylation sites
These methods have been successfully applied to characterize other methyltransferases, such as the novel protein arginine methyltransferase described in S. cerevisiae studies .
While specific optimal conditions for MAP_0882c have not been established in the provided search results, typical conditions for S-adenosyl-L-methionine-dependent methyltransferases provide a starting point for optimization:
Buffer composition:
| Component | Typical Range | Notes |
|---|---|---|
| Buffer | HEPES, Tris, or phosphate | pH 7.0-8.5 |
| NaCl | 50-150 mM | Adjust for optimal ionic strength |
| MgCl₂ | 1-5 mM | Many methyltransferases require divalent cations |
| DTT or β-ME | 1-5 mM | Maintains reduced state of cysteines |
| Glycerol | 5-10% | Enhances protein stability |
| BSA | 0.1-1.0 mg/ml | Prevents non-specific adsorption |
Reaction parameters:
| Parameter | Suggested Range | Optimization Approach |
|---|---|---|
| Temperature | 30-42°C | Test at 30°C, 37°C, and 42°C (relevant to mycobacterial growth) |
| pH | 7.0-9.0 | Test in 0.5 pH unit increments |
| [SAM] | 10-200 μM | Determine Km by varying concentration |
| [Substrate] | Dependent on substrate type | Test multiple potential substrates |
| Enzyme concentration | 10-500 nM | Use minimum amount that gives detectable activity |
| Incubation time | 15-120 minutes | Establish linearity of the reaction |
Optimization strategy:
Perform initial activity screening using potential substrates
Once activity is detected, systematically vary each parameter while keeping others constant
Use statistical design of experiments (DoE) for efficient optimization
Determine kinetic parameters (Km, kcat) under optimal conditions
Test for potential activators or inhibitors
Verify optimal conditions across different substrate types if applicable
Similar systematic approaches have been used for characterizing other methyltransferases, such as the putative methyltransferase LaeA described in the literature .
Identifying the substrates of MAP_0882c requires a multi-faceted experimental design:
Bioinformatic prediction:
Analyze the protein structure and identify potential substrate-binding regions
Compare with characterized methyltransferases to infer substrate preferences
Examine genomic context for functional associations
Use protein-protein interaction networks to identify potential protein substrates
Candidate substrate screening:
Based on bioinformatic predictions, test likely substrate categories:
DNA (genomic DNA, methylation-sensitive restriction digestion)
RNA (total RNA, specific RNA classes)
Proteins (histones, transcription factors, metabolic enzymes)
Small molecules (metabolites, cell wall components)
Develop a medium-throughput screening assay that can detect methylation activity
Test systematically across substrate candidates
Unbiased substrate identification:
Activity-based protein profiling:
Synthesize SAM analogs with clickable or affinity handles
Incubate with cell lysate in the presence of MAP_0882c
Capture labeled substrates and identify by mass spectrometry
Comparative methylome analysis:
Generate MAP_0882c knockout or overexpression strains
Compare global methylation patterns using:
Methylation-specific antibodies
Mass spectrometry-based proteomics
Methylation-sensitive restriction enzyme analysis for DNA
Proximity labeling:
Create a MAP_0882c fusion with a promiscuous biotin ligase (BioID, TurboID)
Express in mycobacterial cells
Identify biotinylated proteins as potential interactors or substrates
Validation experiments:
Confirm direct methylation using purified components
Map methylation sites by mass spectrometry
Generate methylation-deficient mutants of the substrate
Assess functional consequences of methylation
This experimental design follows principles of optimal experimental design as described in the literature, with sequential refinement of hypotheses based on initial findings .
A comprehensive comparison of MAP_0882c with other bacterial methyltransferases would involve structural, sequence, and functional analyses:
Sequence comparison:
The S-adenosyl-L-methionine-dependent methyltransferase family exhibits considerable sequence diversity outside the conserved motifs. Comparing MAP_0882c to well-characterized methyltransferases reveals:
MAP_0882c contains 304 amino acids , within the typical range for bacterial methyltransferases
Like other mycobacterial proteins, it may contain specific sequence adaptations for its environment
Alignment with other methyltransferases would focus on:
Conservation of catalytic residues
Differences in substrate-binding regions
Presence of regulatory domains
Structural comparison:
While no experimental structure for MAP_0882c is reported in the search results, structural predictions could reveal:
Conservation of the core Rossmann-like fold for SAM binding
Unique structural features that might determine substrate specificity
Potential regulatory domains or protein-protein interaction interfaces
Comparison with structures of characterized methyltransferases such as:
DNA methyltransferases (e.g., Dam, Dcm)
Protein methyltransferases (e.g., PRMT family)
RNA methyltransferases
Small molecule methyltransferases
Functional comparison:
MAP_0882c function can be compared to other characterized methyltransferases:
DNA methyltransferases: Primarily involved in epigenetic regulation and protection against restriction enzymes
Protein methyltransferases: Like Rmt2 in yeast , modify proteins to alter their function, stability, or interactions
RNA methyltransferases: Modify rRNA, tRNA, or mRNA to affect translation or RNA stability
Small molecule methyltransferases: Participate in biosynthesis of antibiotics, cell wall components, or metabolites
A systematic comparison would help position MAP_0882c within the broader methyltransferase family and provide insights into its potential function in Mycobacterium paratuberculosis biology.
The potential role of MAP_0882c in pathogenesis can be investigated through several interconnected research approaches:
Genetic approaches:
Generate knockout mutants using specialized mycobacterial genetic tools
Evaluate phenotypic changes in:
Growth kinetics
Virulence in cell culture and animal models
Stress responses (pH, oxidative stress, nutrient limitation)
Drug susceptibility
Perform complementation studies to confirm phenotype specificity
Create point mutants targeting catalytic residues to confirm methyltransferase activity is responsible for the phenotype
Transcriptomic and proteomic analyses:
Compare gene expression profiles between wild-type and MAP_0882c mutants
Identify differentially regulated pathways, particularly those related to:
Cell wall synthesis
Metabolic adaptation
Immune evasion
Stress response
Examine expression of MAP_0882c itself under different conditions:
During infection
Under various stress conditions
In different growth phases
Substrate identification and characterization:
Identify methylation targets of MAP_0882c
Determine the functional consequences of methylation on these targets
Link methylation events to specific aspects of bacterial physiology or host interaction
Comparative analyses:
Analyze conservation of MAP_0882c across mycobacterial species
Compare virulence between strains with different expression levels of MAP_0882c
Examine the role of homologous methyltransferases in other pathogenic bacteria
Based on studies of other methyltransferases, MAP_0882c might contribute to pathogenesis through:
Modification of cell wall components to alter host recognition
Regulation of gene expression under stress conditions
Post-translational modification of virulence factors
Methylation of metabolites that interface with host immunity
This approach aligns with investigations of other bacterial methyltransferases where deletion mutants revealed phenotypes related to virulence, such as described for LaeA in fungal systems .
The multiple-probe experimental design (MPD) offers a robust framework for investigating MAP_0882c function in applied settings. This approach can be adapted from the PEAK relational training system described in the literature :
Experimental design structure:
Baseline probes:
Direct testing of MAP_0882c function before intervention
Measurement of methylation activity across multiple potential substrates
Assessment of growth phenotypes in wild-type organisms
Temporal staggering:
Introduction of interventions (gene knockout, inhibitor treatment, substrate modification) at different time points
Continuous monitoring of phenotypic outcomes
Maintenance of untreated controls throughout the experiment
Mastery criteria:
Establishment of clear endpoints for functional characterization
Definition of statistical thresholds for significant effects
Standardized protocols for phenotypic evaluation
Implementation for MAP_0882c:
| Phase | Components | Measurements | Analysis |
|---|---|---|---|
| Baseline | - Wild-type cultures - Multiple substrate candidates - Control methyltransferase assays | - Growth curves - Methyltransferase activity - Gene expression levels | - Establish normal activity range - Identify potential substrates - Determine expression patterns |
| Intervention | - MAP_0882c knockout - MAP_0882c overexpression - Site-directed mutants - Enzyme inhibitors | - Changes in growth phenotype - Substrate methylation levels - Global methylation patterns | - Determine functional consequences - Validate target specificity - Assess compensatory mechanisms |
| Validation | - Complementation studies - In vitro reconstitution - Host-pathogen models | - Restoration of phenotype - Direct enzyme-substrate interaction - Virulence assessment | - Confirm causal relationships - Establish biochemical mechanisms - Determine pathogenic relevance |
Advantages of the MPD approach:
Allows direct testing of MAP_0882c function through multiple independent measures
Temporal staggering provides internal validation and controls for time-dependent effects
Clear mastery criteria establish when sufficient evidence has been gathered
The design can evolve based on initial findings
Failed experiments can be remedied through systematic adjustments
This experimental design aligns with the scientist-practitioner model described in the literature , enabling rigorous investigation while maintaining flexibility for practical constraints in mycobacterial research.
The effect of mutations in the SAM-binding motifs of MAP_0882c can be systematically investigated through a structure-function analysis approach:
Key SAM-binding motifs to target:
Motif I (GxG): Essential for SAM binding, creates a loop structure that accommodates the methionine portion of SAM
Motif II (YxG): Involved in positioning the substrate for methyl transfer
Motif III (RFINHxCxPN): Contains catalytically important residues
Motif IV (ELxFDY): Contributes to the structural integrity of the active site
Mutational strategy:
| Motif | Mutations to Test | Predicted Effects |
|---|---|---|
| I (GxG) | G→A (conservative) G→V (disruptive) | Reduced SAM binding affinity Complete loss of SAM binding |
| II (YxG) | Y→F (conservative) Y→A (disruptive) | Altered substrate positioning Loss of substrate recognition |
| III (RFINHxCxPN) | R→K (conservative) R→A (disruptive) H→A (catalytic) | Reduced catalytic efficiency Inactivation Loss of proton transfer capability |
| IV (ELxFDY) | E→D (conservative) E→A (disruptive) | Minimal effect on structure Destabilization of active site |
Functional characterization:
Biochemical analysis:
Measure SAM binding affinity (isothermal titration calorimetry)
Determine enzyme kinetics (Km, kcat, catalytic efficiency)
Assess thermal stability (differential scanning fluorimetry)
Examine substrate specificity changes
Structural analysis:
Obtain crystal structures of wild-type and mutant proteins
Perform molecular dynamics simulations
Analyze changes in protein dynamics and flexibility
In vivo characterization:
Complement MAP_0882c knockout with mutant variants
Assess phenotypic rescue
Measure methylation activity in cellular context
Evaluate effects on bacterial physiology
Similar approaches have been successfully applied to other methyltransferases. For example, studies on the LaeA methyltransferase demonstrated that mutations in the SAM-binding domain (LaeAM1, LaeAM2, and LaeAM3) abolished its ability to regulate fungal physiology, confirming that methyltransferase activity is essential for its function .
Resolving conflicting data regarding MAP_0882c enzymatic activity requires a systematic approach combining critical evaluation, experimental validation, and reconciliation of different observations:
Critical evaluation of existing data:
Methodological differences:
Compare assay types (radiometric, mass spectrometry, coupled assays)
Examine reaction conditions (buffer composition, pH, temperature)
Review protein preparation methods (purification strategy, tags, storage)
Assess substrate sources and purity
Data quality assessment:
Evaluate statistical significance and reproducibility
Check for appropriate controls
Examine dose-response relationships
Consider potential artifacts or confounding factors
Targeted validation experiments:
Standardized conditions:
Establish uniform experimental protocols
Use consistent protein preparations
Test multiple substrate batches
Include positive and negative controls
Orthogonal methodologies:
Validate activity using independent assay techniques
Confirm substrate identity by multiple methods
Test in different biological contexts
Employ complementary structural analyses
Resolution approaches:
Multiple substrate hypothesis:
Test if MAP_0882c methylates different substrates under different conditions
Examine substrate competition
Measure relative activities toward different substrates
Regulatory mechanisms:
Investigate allosteric regulation
Test for post-translational modifications of MAP_0882c
Examine the effect of potential cofactors or binding partners
Study the effect of product inhibition
Structural flexibility:
Analyze if the enzyme adopts different conformations
Examine the effect of buffer components on structure
Test for oligomerization-dependent activity changes
Collaborative validation:
Exchange reagents and protocols between laboratories
Conduct blind validation experiments
Perform round-robin testing of the same samples
Develop consensus quality control criteria
This systematic approach aligns with the principles of optimal experimental design described in the literature , allowing for efficient resolution of conflicting data through sequential hypothesis testing and validation.
Predicting the substrates and functions of MAP_0882c requires an integrated bioinformatic approach combining sequence, structure, and systems biology methods:
Sequence-based approaches:
Homology analysis:
BLAST searches against characterized methyltransferases
Multiple sequence alignment to identify conserved catalytic residues
Phylogenetic analysis to place MAP_0882c within methyltransferase families
Examination of substrate-determining regions
Domain and motif analysis:
Identification of additional functional domains
Detection of substrate-binding motifs
Analysis of post-translational modification sites
Prediction of subcellular localization signals
Structure-based approaches:
Homology modeling:
Generation of 3D structural models using AlphaFold or similar tools
Validation of models using energy minimization and Ramachandran plots
Comparison with crystal structures of related methyltransferases
Active site analysis:
Identification of the substrate-binding pocket
Characterization of electrostatic and hydrophobic properties
Comparison with substrate-binding sites of characterized methyltransferases
Virtual screening of potential substrates
Systems biology approaches:
Genomic context analysis:
Examination of neighboring genes for functional associations
Identification of operons or regulons containing MAP_0882c
Comparative genomics across mycobacterial species
Analysis of gene fusion events
Network-based predictions:
Construction of protein-protein interaction networks
Pathway enrichment analysis of potential interactors
Co-expression analysis from transcriptomic data
Metabolic network analysis for small molecule substrates
Integrative analysis workflow:
Generate initial hypotheses using sequence-based methods
Refine predictions using structural modeling
Contextualize findings within biological networks
Prioritize candidate substrates for experimental validation
Design targeted assays based on bioinformatic predictions
This comprehensive bioinformatic approach leverages multiple lines of evidence to make informed predictions about MAP_0882c function, similar to the methodologies used to identify and characterize other methyltransferases in the literature .
Analyzing the kinetics of MAP_0882c-catalyzed methylation reactions requires a systematic approach to determine reaction mechanisms and kinetic parameters:
Steady-state kinetic analysis:
Initial velocity measurements:
Measure reaction rates at varying substrate concentrations
Ensure linearity with respect to time and enzyme concentration
Maintain [S] >> [E] to satisfy steady-state assumptions
Include controls for background activity
Kinetic model fitting:
For single-substrate kinetics (considering SAM as constant):
For bi-substrate kinetics (varying both SAM and substrate):
Use non-linear regression for parameter estimation
Determination of kinetic parameters:
Km (substrate concentration at half-maximal velocity)
kcat (catalytic constant, turnover number)
kcat/Km (catalytic efficiency)
Ki values for inhibitors
Reaction mechanism determination:
Product inhibition studies:
Test inhibition by S-adenosylhomocysteine (SAH)
Determine competitive, uncompetitive, or mixed inhibition patterns
Analyze double-reciprocal plots for mechanism insights
Dead-end inhibitor studies:
Use SAM analogs to probe binding order
Test substrate analogs that bind but aren't methylated
Determine inhibition patterns to infer binding order
Isotope effects:
Measure kinetic isotope effects using deuterated substrates
Identify rate-limiting steps in the reaction
Probe transition state structures
Data analysis and visualization:
| Plot Type | Purpose | Interpretation |
|---|---|---|
| Michaelis-Menten | Primary data visualization | Direct determination of Vmax and apparent Km |
| Lineweaver-Burk (double-reciprocal) | Mechanism investigation | Pattern of lines indicates reaction mechanism |
| Eadie-Hofstee | Alternative linearization | Less sensitive to errors at high substrate concentration |
| Dixon plots | Inhibitor analysis | Determination of inhibition type and Ki values |
Advanced kinetic analyses:
Pre-steady-state kinetics:
Use rapid kinetic techniques (stopped-flow, quench-flow)
Measure rates of individual steps in the reaction
Identify transient intermediates
Determine rate-limiting steps
Global data fitting:
Simultaneously fit multiple datasets to complex models
Use specialized software (DynaFit, KinTek Explorer)
Test alternative mechanisms statistically
Simulate reaction progress under various conditions
These methodologies follow established principles for enzyme kinetic analysis and can be applied to MAP_0882c to thoroughly characterize its catalytic mechanism and efficiency.
Recombinant MAP_0882c, as a putative S-adenosyl-L-methionine-dependent methyltransferase, has several potential biotechnological applications beyond its use in basic research:
Synthetic biology applications:
Biosynthesis of methylated compounds:
Production of methylated natural products
Synthesis of methylated pharmaceuticals
Generation of methylated building blocks for chemical synthesis
Conversion of bio-based feedstocks to value-added methylated compounds
Pathway engineering:
Introduction of novel methylation capabilities into production organisms
Modification of existing methyltransferase specificity
Creation of new-to-nature methylated metabolites
Regulation of metabolic pathways through targeted methylation
Biotechnological tools:
Molecular biology applications:
Site-specific methylation of nucleic acids
Modulation of gene expression through targeted methylation
Creation of methylation-sensitive restriction sites
Development of methylation-based selection markers
Protein engineering:
Post-translational modification of recombinant proteins
Alteration of protein stability, solubility, or activity
Generation of methylated peptides for therapeutic applications
Development of methylation-sensitive biosensors
Diagnostic and analytical applications:
Biomarker analysis:
Detection of methylated biomolecules as disease markers
Quantification of methylation levels in clinical samples
Monitoring of methylation changes during disease progression
Development of methylation-specific analytical methods
Structural biology tools:
Methylation-assisted crystallization
Stabilization of proteins for structural studies
NMR analysis of methylated biomolecules
Mass spectrometry enhancement through methylation
Therapeutic applications:
Vaccine development:
Drug development:
Target for antimycobacterial drugs
Screening platform for methyltransferase inhibitors
Production of methylated therapeutics
Enzyme replacement therapy for methylation disorders
These applications leverage the catalytic capabilities of MAP_0882c while considering its potential substrate specificity and reaction characteristics. As with any biotechnological application, thorough characterization of the enzyme's properties would be required before implementation in specific processes.